The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the EU/EEA is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC).
Avian influenza viruses (AIV) remain prevalent among wild bird populations in the European Union and European Economic Area (EU/EEA), leading to significant illness in and death of birds.
Influenza is a disease of public health importance due to the substantial seasonal morbidity and mortality and the high pandemic potential of its aetiologic agents, influenza viruses.
This document presents the core protocol for ECDC studies of CVE and IVE against symptomatic laboratory-confirmed influenza or SARS-CoV-2 infection, respectively, at primary care level.
This report provides an overview of highly pathogenic avian influenza (HPAI) virus detections in poultry, captive and wild birds that occurred in and outside Europe between 24 June and 1 September 2023, as well as HPAI virus detections in mammals (up to 15 September 2023) and human cases due to avian influenza virus (up to 14 September
2023).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 July 2023 and includes updates on avian influenza, Echovirus 11, COVID-19, West Nile virus, poliomyelitis, and botulism.